Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Priority claimed from PCT/IB2020/050310external-prioritypatent/WO2020148677A1/en
Publication of CR20210382ApublicationCriticalpatent/CR20210382A/en
101710174800G-protein coupled receptor family C group 5 member DProteins0.000abstract1
101001040713Homo sapiens G-protein coupled receptor family C group 5 member DProteins0.000abstract1
206010028980NeoplasmDiseases0.000abstract1
201000011510cancerDiseases0.000abstract1
Landscapes
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a G-protein coupled receptor, G-protein coupled receptor family C group 5 member D (GPRC5D), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
CR20210382A2019-01-182020-01-15Gprc5d chimeric antigen receptors and cells expressing the same
CR20210382A
(en)